Skip to content

008490.KS

Suheung Co., Ltd.

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 21,350.00
−0.23%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue765.9B722.3B653.3B594.6B635.0B
Cost of Revenue631.3B599.0B550.0B495.5B497.7B
Gross Profit134.6B123.3B103.2B99.0B137.3B
Operating Expenses
R&D Expense9.2B9.5B7.9B7.0B7.4B
SG&A Expense44.5B35.9B27.0B26.2B41.5B
General & Admin Expense3.3B3.9B3.9B3.4B3.1B
Selling & Marketing Expense32.6B32.0B23.1B22.9B38.4B
Other Expenses25.9B27.2B34.6B22.8B26.4B
Total Operating Expenses77.0B72.6B69.4B56.0B75.3B
Cost and Expenses703.8B672.1B619.4B551.6B573.0B
Operating Income (EBIT)62.3B50.7B33.8B43.0B62.0B
Non-Operating
Interest Income2.9B2.8B2.7B1.7B772.6M
Interest Expense16.6B17.6B21.0B19.7B11.2B
Net Interest Income(13.7B)(14.8B)(18.3B)(18.0B)(10.4B)
Other Non-Op Income/Expense(1.0B)3.1B(2.6B)(29.0B)(10.0B)
Non-Operating Income (excl Interest)(9.4B)(20.7B)(18.4B)2.3B(1.2B)
EBT (Pre-Tax Income)61.2B53.8B31.2B14.0B51.9B
Income Tax Expense13.6B6.6B9.7B5.1B11.3B
Bottom Line
Net Income39.1B43.5B18.3B6.1B34.0B
Earnings from Cont. Ops47.7B47.1B21.6B15.9B40.6B
Earnings from Discont. Ops
Bottom Line Net Income39.1B43.5B18.3B6.1B34.0B
Per Share
Basic EPS₩3,517₩3,911₩1,643₩550₩3,056
Diluted EPS₩3,517₩3,911₩1,643₩550₩3,056
Revenue Per Share₩68,777₩62,435₩58,752₩53,473₩57,106
Shares
Basic Shares Outstanding11.1M11.6M11.1M11.1M11.1M
Diluted Shares Outstanding11.1M11.6M11.1M11.1M11.1M
Profitability Metrics
EBITDA78.7B91.2B73.5B77.0B98.6B
D&A41.7B40.5B39.9B36.3B35.4B
EBIT36.9B50.7B33.6B40.7B63.2B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026